Partners Ed Burbach and Frank Pasquesi have co-authored an article for Corporate Counsel, “2019: New Attorneys General and New Priorities,” about significant recent developments evidencing an increase in state AG activity throughout the country.
The article notes that there are 17 new state attorney generals this year, helping to make up what may be the most racially and gender diverse collection of state attorney generals in history. Moreover, the majority have backgrounds in legislative bodies or state agencies, rather than as prosecutors or in the judiciary, which suggests that policymaking through investigation and enforcement is becoming the norm. And, as those attorney generals become more active, the authors conclude, it is more important than ever to have on-the-ground local state attorney general experience.
(Subscription required.)
The article notes that there are 17 new state attorney generals this year, helping to make up what may be the most racially and gender diverse collection of state attorney generals in history. Moreover, the majority have backgrounds in legislative bodies or state agencies, rather than as prosecutors or in the judiciary, which suggests that policymaking through investigation and enforcement is becoming the norm. And, as those attorney generals become more active, the authors conclude, it is more important than ever to have on-the-ground local state attorney general experience.
(Subscription required.)
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”